News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
382,195 Results
Type
Article (25935)
Company Profile (60)
Press Release (356200)
Multimedia
Podcasts (26)
Webinars (7)
Section
Business (104265)
Career Advice (450)
Deals (16873)
Drug Delivery (51)
Drug Development (47598)
Employer Resources (47)
FDA (12265)
Job Trends (8443)
News (185937)
Policy (19425)
Tag
Academia (1750)
Accelerated approval (3)
Adcomms (8)
Allergies (74)
Alliances (26752)
ALS (57)
Alzheimer's disease (812)
Antibody-drug conjugate (ADC) (56)
Approvals (12327)
Artificial intelligence (172)
Autoimmune disease (10)
Automation (4)
Bankruptcy (142)
Best Places to Work (6893)
BIOSECURE Act (5)
Biosimilars (36)
Biotechnology (40)
Bladder cancer (59)
Brain cancer (17)
Breast cancer (203)
Cancer (1461)
Cardiovascular disease (122)
Career advice (407)
Career pathing (13)
CAR-T (72)
Cell therapy (205)
Cervical cancer (14)
Clinical research (40564)
Collaboration (450)
Compensation (134)
Complete response letters (9)
COVID-19 (1493)
CRISPR (14)
C-suite (147)
Cystic fibrosis (43)
Data (1588)
Decentralized trials (2)
Denatured (18)
Depression (31)
Diabetes (178)
Diagnostics (3527)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (52)
Drug pricing (55)
Drug shortages (21)
Duchenne muscular dystrophy (56)
Earnings (37091)
Editorial (22)
Employer branding (6)
Employer resources (44)
Events (51890)
Executive appointments (454)
FDA (13314)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (410)
Gene editing (40)
Generative AI (10)
Gene therapy (130)
GLP-1 (406)
Government (3038)
Grass and pollen (3)
Guidances (93)
Healthcare (12186)
Huntington's disease (10)
IgA nephropathy (16)
Immunology and inflammation (42)
Indications (19)
Infectious disease (1565)
Inflammatory bowel disease (82)
Inflation Reduction Act (4)
Influenza (27)
Intellectual property (51)
Interviews (40)
IPO (7043)
IRA (19)
Job creations (1840)
Job search strategy (378)
Kidney cancer (7)
Labor market (13)
Layoffs (172)
Leadership (4)
Legal (3632)
Liver cancer (57)
Lung cancer (234)
Lymphoma (100)
Machine learning (4)
Management (17)
Manufacturing (111)
MASH (53)
Medical device (12912)
Medtech (12915)
Mergers & acquisitions (10131)
Metabolic disorders (444)
Multiple sclerosis (55)
NASH (11)
Neurodegenerative disease (49)
Neuropsychiatric disorders (9)
Neuroscience (1151)
NextGen: Class of 2025 (3930)
Non-profit (2822)
Now hiring (17)
Obesity (221)
Opinion (70)
Ovarian cancer (56)
Pain (66)
Pancreatic cancer (56)
Parkinson's disease (90)
Partnered (11)
Patents (117)
Patient recruitment (84)
Peanut (37)
People (34739)
Pharmaceutical (17)
Pharmacy benefit managers (12)
Phase I (11617)
Phase II (17561)
Phase III (14428)
Pipeline (762)
Policy (62)
Postmarket research (1668)
Preclinical (3623)
Press Release (18)
Prostate cancer (77)
Psychedelics (17)
Radiopharmaceuticals (160)
Rare diseases (186)
Real estate (2846)
Recruiting (16)
Regulatory (14232)
Reports (17)
Research institute (1607)
Resumes & cover letters (48)
Rett syndrome (2)
RNA editing (2)
RSV (20)
Schizophrenia (52)
Series A (67)
Series B (50)
Service/supplier (3)
Sickle cell disease (22)
Special edition (4)
Spinal muscular atrophy (102)
Sponsored (13)
Startups (2121)
Stomach cancer (8)
Supply chain (38)
Tariffs (14)
The Weekly (8)
Vaccines (359)
Venture capitalists (13)
Weight loss (141)
Women's health (18)
Worklife (4)
Date
Today (35)
Last 7 days (474)
Last 30 days (1593)
Last 365 days (18281)
2025 (6375)
2024 (19849)
2023 (22736)
2022 (30680)
2021 (32984)
2020 (32190)
2019 (28412)
2018 (21810)
2017 (18906)
2016 (18111)
2015 (21194)
2014 (16023)
2013 (13241)
2012 (14356)
2011 (14625)
2010 (13181)
Location
Africa (354)
Alabama (17)
Alaska (2)
Arizona (119)
Arkansas (10)
Asia (24574)
Australia (3892)
California (3156)
Canada (1248)
China (378)
Colorado (167)
Connecticut (175)
Delaware (122)
Europe (48004)
Florida (562)
Georgia (129)
Idaho (33)
Illinois (364)
India (14)
Indiana (228)
Iowa (3)
Japan (125)
Kansas (74)
Kentucky (12)
Louisiana (8)
Maine (27)
Maryland (646)
Massachusetts (2197)
Michigan (108)
Minnesota (276)
Mississippi (2)
Missouri (52)
Montana (18)
Nebraska (18)
Nevada (35)
New Hampshire (60)
New Jersey (1158)
New Mexico (9)
New York (981)
North Carolina (563)
North Dakota (4)
Northern California (1387)
Ohio (133)
Oklahoma (3)
Oregon (23)
Pennsylvania (851)
Puerto Rico (7)
Rhode Island (24)
South America (520)
South Carolina (23)
Southern California (1214)
Tennessee (79)
Texas (560)
United States (13133)
Utah (115)
Virginia (82)
Washington D.C. (42)
Washington State (231)
West Virginia (3)
Wisconsin (43)
382,195 Results for "contego medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Dr. Mitchell J. Silver Joins Contego Medical as Chief Medical Officer
Focuses on Company’s Clinical Strategy for Carotid and Thrombectomy Devices
August 8, 2024
·
2 min read
Bio NC
Contego Medical Announces One-Year Outcomes From the Performance II Carotid Stent Trial
Contego Medical Inc., a company dedicated to improving patient outcomes and procedural efficiency in the treatment of carotid and peripheral vascular disease, today announced the presentation of late-breaking clinical results from the PERFORMANCE II carotid stent trial at the annual VIVA (Vascular InterVentional Advances) multidisciplinary vascular education conference.
November 1, 2023
·
3 min read
Bio NC
Contego Medical Completes Enrollment of the PERFORMANCE II Carotid Stent Trial
Contego Medical, Inc. announced that enrollment of the PERFORMANCE II clinical trial has been completed. PERFORMANCE II is designed to evaluate the safety and effectiveness of the Neuroguard IEP® 3-in-1 Carotid Stent and Post-Dilation Balloon System with Integrated Embolic Protection.
November 14, 2022
·
3 min read
Bio NC
Contego Medical Receives CE Mark Approval for Next Generation Carotid Stent
Contego Medical, Inc., a leading developer of innovative cardiovascular devices, announced receipt of CE Mark approval for the Neuroguard IEP® 3-in-1 Carotid Stent and Post-Dilation Balloon System with Integrated Embolic Protection.
April 16, 2021
·
2 min read
Press Releases
Tenon Medical(R) Receives Approval for Notice of Allowance from the European Patent Office
March 11, 2025
·
2 min read
Press Releases
Tenon Medical(R) Announces FDA Clearance of Catamaran(R) SI Joint Fusion System for New Indication to Augment Spinal Fusion
March 24, 2025
·
2 min read
Bio NC
Contego Medical Announces the Start of Enrollment in the PERFORMANCE II Carotid Stenting Clinical Trial
Contego Medical, Inc. announced enrollment of the first patient in the PERFORMANCE II Trial evaluating the safety and effectiveness of the Neuroguard IEP® 3 in 1 Carotid Stent and Post-Dilation Balloon System with Integrated Embolic Protection.
June 15, 2020
·
3 min read
Press Releases
ICU Medical Announces First Quarter 2025 Results
May 9, 2025
·
20 min read
Press Releases
AVITA Medical Reports First Quarter 2025 Financial Results
May 9, 2025
·
11 min read
Press Releases
Trial Finds Inquis Medical’s AVENTUS Thrombectomy System Safe and Effective for Patients with Pulmonary Embolism
May 2, 2025
·
4 min read
1 of 38,220
Next
